Hengrui Medicine (600276.SH): The final price for the issuance of H shares has been determined to be HK$44.05 per share.

Wisdom Financial News APP reports that Jiangsu Hengrui Medicine (600276.SH) has announced that the final price for the H shares issue has been set at HK$44.05 per share. This price does not include 1% brokerage commission, 0.0027% Securities and Futures Commission levy, 0.00565% Hong Kong Stock Exchange trading fee, and 0.00015% Hong Kong Institute of Accountants trading levy. The H shares are expected to be listed on the Main Board of the Hong Kong Stock Exchange and commence trading on May 23, 2025.